Shares of SciClone Pharma (SCLN) resume trading down nearly 12%
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Join SI Premium – FREE
Shares of SciClone Pharma (Nasdaq: SCLN) resume trading down nearly 12 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- This EU stock is Berenberg's top pick in luxury
- Buy this stock to gain "growing AI/HPC exposure": Barclays
- Value-focused retailer sees traffic momentum strengthen ahead of second quarter
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
